Doe & Ingalls unveils a cold room first

Doe & Ingalls, a US chemical supply chain manager and distributor, has announced the addition of a cGMP-compliant 2-8°C cold room for off-site storage of bio-manufacturing components. Located at its Maryland facility, the development, the company maintains, “is a first in biotechnology chemical distribution”, allowing customers to have material available with quick turnaround but without the expense of having to build and maintain their own cGMP cold storage rooms.

“There is limited cGMP-compliant cold storage space available in the US for cell culture media, supplements and bioprocessing reagents,” says John Hollenbach, director of sales and marketing.

“Our new cold storage capabilities allow both suppliers and customers to use us as part of their cold chain risk-mitigation plans. We’ve been an integral part of our customers’ supply chain for over 20 years, so it was natural to offer cold chain services to further secure their chemical supply chains,” he reasons.

Cold storage maintains the stability of critical raw materials vital to manufacturing of biopharmaceuticals, such as vaccines and drugs. Safeguards to the cold room include adherence to the CFR 210 and 211 guidelines for storing and handling materials, redundant refrigeration systems, back-up power generation and temperature control devices and charting, with the company asserting that features such as these “are increasingly important to assuring the stability of raw materials used in biotechnology applications”.

www.doeingalls.com